Cargando…

[(18)F]THK-5351 PET Patterns in Patients With Alzheimer’s Disease and Negative Amyloid PET Findings

BACKGROUND AND PURPOSE: Alzheimer’s disease (AD) does not always mean amyloid positivity. [(18)F]THK-5351 has been shown to be able to detect reactive astrogliosis as well as tau accompanied by neurodegenerative changes. We evaluated the [(18)F]THK-5351 retention patterns in positron-emission tomogr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Minyoung, Oh, Jungsu S., Oh, Seung Jun, Lee, Sang Ju, Roh, Jee Hoon, Kim, Woo Ram, Seo, Ha-Eun, Kang, Jae Myeong, Seo, Sang Won, Lee, Jae-Hong, Na, Duk L., Noh, Young, Kim, Jae Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262461/ https://www.ncbi.nlm.nih.gov/pubmed/35796269 http://dx.doi.org/10.3988/jcn.2022.18.4.437

Ejemplares similares

(18)F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment
por: Chun, Min Young, et al.
Publicado: (2022)

Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer’s disease
por: Kim, Minjae, et al.
Publicado: (2021)

Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer’s disease differ according to disease severity and amyloid positivity
por: Park, Ji Eun, et al.
Publicado: (2019)

(18)F–THK–5351, Fluorodeoxyglucose, and Florbetaben PET Images in Atypical Alzheimer’s Disease: A Pictorial Insight into Disease Pathophysiology
por: Park, Sohee, et al.
Publicado: (2021)

[(18)F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment
por: Jeong, Hye Jin, et al.
Publicado: (2020)

(18)F-THK5351 PET Imaging in the Behavioral Variant of Frontotemporal Dementia
por: Nam, Gijin, et al.
Publicado: (2018)

THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report
por: Kim, Hee Jin, et al.
Publicado: (2019)

(18)F-THK5351 PET Imaging in Nonfluent-Agrammatic Variant Primary Progressive Aphasia
por: Yoon, Cindy W, et al.
Publicado: (2018)

Relationships between [(18)F]-THK5351 Retention and Language Functions in Primary Progressive Aphasia
por: Jeong, Hye Jin, et al.
Publicado: (2019)

Diagnostic accuracy of (18)F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
por: Oh, Minyoung, et al.
Publicado: (2023)

Striatofrontal Deafferentiation in MSA-P: Evaluation with [(18)F]FDG Brain PET
por: Kim, Hae Won, et al.
Publicado: (2017)

Neuroimaging-pathological correlations of [(18)F]THK5351 PET in progressive supranuclear palsy
por: Ishiki, Aiko, et al.
Publicado: (2018)

[(18)F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy
por: Brendel, Matthias, et al.
Publicado: (2018)

High sensitivity of asymmetric (18)F-THK5351 PET abnormality in patients with corticobasal syndrome
por: Kurihara, Masanori, et al.
Publicado: (2023)

Perfusion-Phase [(18)F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration
por: Brendel, Matthias, et al.
Publicado: (2017)

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
por: Lemoine, Laetitia, et al.
Publicado: (2017)

Error propagation analysis of seven partial volume correction algorithms for [(18)F]THK-5351 brain PET imaging
por: Oyama, Senri, et al.
Publicado: (2020)

(18)F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty
por: Hsu, Jung-Lung, et al.
Publicado: (2020)

Longitudinal Assessment of Tau-Associated Pathology by (18)F-THK5351 PET Imaging: A Histological, Biochemical, and Behavioral Study
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2021)

Effects of Cognitive Reserve in Alzheimer’s Disease and Cognitively Unimpaired Individuals
por: Lee, Dong Hyuk, et al.
Publicado: (2022)

(18)F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Ezura, Michinori, et al.
Publicado: (2021)

Tau PET With (18)F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H Mutation
por: Huang, Chin-Chang, et al.
Publicado: (2019)

Author Correction: (18)F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty
por: Hsu, Jung-Lung, et al.
Publicado: (2021)

(18)F-THK5351 PET for visualizing predominant lesions of pathologically confirmed corticobasal degeneration presenting with frontal behavioral-spatial syndrome
por: Saitoh, Yuji, et al.
Publicado: (2022)

Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer’s Continuum
por: Hwang, Jihye, et al.
Publicado: (2021)

Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
por: Lockhart, Samuel N., et al.
Publicado: (2016)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
por: Kim, Hyung-Ji, et al.
Publicado: (2022)

Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants
por: Schaeverbeke, Jolien, et al.
Publicado: (2018)

Visualization of ischemic stroke-related changes on (18)F-THK-5351 positron emission tomography
por: Huang, Kuo-Lun, et al.
Publicado: (2018)

Diagnostic accuracy of dual-phase (18)F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism
por: Oh, Minyoung, et al.
Publicado: (2021)

Early brainstem ([18F])THK5351 uptake is linked to cortical hyperexcitability in healthy aging
por: Van Egroo, Maxime, et al.
Publicado: (2021)

[(18)F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review
por: Kobayashi, Ryota, et al.
Publicado: (2018)

Different subregional metabolism patterns in patients with cerebellar ataxia by (18)F-fluorodeoxyglucose positron emission tomography
por: Oh, Minyoung, et al.
Publicado: (2017)

Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain
por: Ng, Kok Pin, et al.
Publicado: (2017)

Topographical Heterogeneity of Alzheimer’s Disease Based on MR Imaging, Tau PET, and Amyloid PET
por: Jeon, Seun, et al.
Publicado: (2019)

Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using Amyloid PET and Brain MR Imaging Data: A 48-Month Follow-Up Analysis of the Alzheimer’s Disease Neuroimaging Initiative Cohort
por: Kim, Do-Hoon, et al.
Publicado: (2023)

Genetic alterations associated with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma
por: Han, Sangwon, et al.
Publicado: (2020)

Clinical significance of focal ß-amyloid deposition measured by (18)F-flutemetamol PET
por: Kim, Si Eun, et al.
Publicado: (2020)

Dual tracer tau PET imaging reveals different molecular targets for (11)C-THK5351 and (11)C-PBB3 in the Alzheimer brain
por: Chiotis, Konstantinos, et al.
Publicado: (2018)

Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer’s Disease: A PET (THK5351, PiB) and Resting fMRI Study
por: Yokoi, Takamasa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_minfoncitd79ft87gc1qqqsla1